344 related articles for article (PubMed ID: 15651898)
1. Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery.
Berger AB; Vitorino PM; Bogyo M
Am J Pharmacogenomics; 2004; 4(6):371-81. PubMed ID: 15651898
[TBL] [Abstract][Full Text] [Related]
2. Tagging and detection strategies for activity-based proteomics.
Sadaghiani AM; Verhelst SH; Bogyo M
Curr Opin Chem Biol; 2007 Feb; 11(1):20-8. PubMed ID: 17174138
[TBL] [Abstract][Full Text] [Related]
3. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
Li J; Wang G; Ye M; Qin H
Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
[TBL] [Abstract][Full Text] [Related]
4. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
Mehan MR; Ostroff R; Wilcox SK; Steele F; Schneider D; Jarvis TC; Baird GS; Gold L; Janjic N
Adv Exp Med Biol; 2013; 735():283-300. PubMed ID: 23402035
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening.
Fonović M; Bogyo M
Curr Pharm Des; 2007; 13(3):253-61. PubMed ID: 17313359
[TBL] [Abstract][Full Text] [Related]
7. Activity-based proteomics: enzymatic activity profiling in complex proteomes.
Schmidinger H; Hermetter A; Birner-Gruenberger R
Amino Acids; 2006 Jun; 30(4):333-50. PubMed ID: 16773240
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
Xiao H; Suttapitugsakul S; Sun F; Wu R
Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
[TBL] [Abstract][Full Text] [Related]
9. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
10. Activity-based proteomics of lipolytic enzymes.
Birner-Gruenberger R; Hermetter A
Curr Drug Discov Technol; 2007 Jun; 4(1):1-11. PubMed ID: 17630923
[TBL] [Abstract][Full Text] [Related]
11. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
12. Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots.
Roberts AM; Ward CC; Nomura DK
Curr Opin Biotechnol; 2017 Feb; 43():25-33. PubMed ID: 27568596
[TBL] [Abstract][Full Text] [Related]
13. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
[TBL] [Abstract][Full Text] [Related]
14. Fulfilling the promise: drug discovery in the post-genomic era.
Chanda SK; Caldwell JS
Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711
[TBL] [Abstract][Full Text] [Related]
15. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
Eckhard U; Marino G; Butler GS; Overall CM
Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
[TBL] [Abstract][Full Text] [Related]
16. Natural products and their biological targets: proteomic and metabolomic labeling strategies.
Böttcher T; Pitscheider M; Sieber SA
Angew Chem Int Ed Engl; 2010 Apr; 49(15):2680-98. PubMed ID: 20333627
[TBL] [Abstract][Full Text] [Related]
17. What does systems biology mean for drug development?
Schrattenholz A; Soskić V
Curr Med Chem; 2008; 15(15):1520-8. PubMed ID: 18537627
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor focusing: direct selection of drug targets from proteomes using activity-based probes.
Nomanbhoy TK; Rosenblum J; Aban A; Burbaum JJ
Assay Drug Dev Technol; 2003 Feb; 1(1 Pt 2):137-46. PubMed ID: 15090140
[TBL] [Abstract][Full Text] [Related]
19. Chemical proteomics and its impact on the drug discovery process.
Miao Q; Zhang CC; Kast J
Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
